Preview

Yakut Medical Journal

Advanced search

Immunomodulators in the treatment of acute respiratory viral infections

https://doi.org/10.25789/YMJ.2021.74.07

Abstract

The survey contains an analysis of current research on the treatment of acute respiratory viral infections (ARVI) using immunomodulatory drugs available on the Russian market, and the rationality of the use of this type of medicine from the standpoint of evidence-based medicine.

About the Authors

N. A. Lebedeva
Medical Institute M.K. Ammosov NEFU
Russian Federation

Lebedeva Natalya Afanasyevna - Ph.D., associate professor



D. S. Tomin
Medical Institute M.K. Ammosov NEFU
Russian Federation

Tomin Dmitry Sergeevich - resident-otorhinolaryngologist



M. M. Vinokurov
Medical Institute M.K. Ammosov NEFU
Russian Federation

Vinokurov Mikhail Mikhailovich - Doctor of Medical Sciences, Professor, Head of the Department



K. G. Terekhina
Medical Institute M.K. Ammosov NEFU
Russian Federation

Terekhina Katerina Germanovna - ordinator otorhinolaryngologist FSBI APE



References

1. Babkin A.P.Evaluation of clinical efficacy of Derinat in form of spray in practice of district therapist / A.P. Babkin, A.A. Zuikova, O.N. Krasnorutskaya // Medical alphabet. – 2019. – V.9, No 384. – P. 38-46 DOI: 10.33667/2078-5631-2019-1-9(384)-38-46

2. Bulgakova V.A., On issue of immune modulators application in therapy and prevention of respiratory viral infections in children / V.A. Bulgakova //Medical advice– 2016. - No 17. – P. 56-61. DOI: 10.21518/2079-701X2016-17-56-61

3. Varfolomeeva M.I. Rationale for use of Polyoxidonium for treatment and prevention of acute respiratory viral infection / M.I. Varfolomeeva, B.V. Pinegin //Difficult patient. – 2011.-V.6, No9. – P. 38-42.

4. Influence of local application of Polyoxidonium on symptoms and course of acute respiratory viral infection in children: result of multicenter double-blind placebo-controlled study / T.I. Garashchenko, O.V. Karneeva, G.D.Tarasova [et al.] // Consilium Medicum.- 2020. – V22, №3. – P. 80-86. DOI: 10.26442/20751753.2020.3.200091

5. Ganicheva L.M. Analysis of preferences of physicians and pharmacists choosing anti-ARVI drugs for young children / L.M. Ganicheva, M.L. Klishkova //Bulletin of VolgMSU– 2013. – No2. – P. 49-52.

6. Glushkova E.F. Treatment issues of upper respiratory tract infections: new approaches / E.F. Glushkova, T.N. Surovenko //Pediatrics. ConsiliumMedicum, - 2019. - No1. - P. 52-56. DOI: 10.26442/26586630.2019.1.190193

7. Glushkova E.F. Immunomodulatory therapy in patients with upper respiratory tract infections and upper respiratory tract/ E.F. Glushkova, T.N. Surovenko // Medical advice– 2016. - No16. – P. 52-56. DOI: 10.21518/2079-701X-2016-16-80-86

8. Weekly National Newsletter Flu and ARVI 9 week, - 2019.

9. Ibid. - 2021.

10. Zaprudnov A.M. Childhood diseases /A.M. Zaprudnov, K.I. Grigorev, L.A. Charitonova. –– M.: GEOTAR-Media, 2013. -V3. - 752p.

11. Immunotherapy: Guidelines for doctors / Haitova R.M., Ataullahanova R.I. –M.: GEOTARMedia, 2011. - 640 p.

12. Isakov V.A. Immunomodulators in Therapy of Respiratory Infections / V.A. Isakov, D.V. Isakov // Antibiotics and Chemotherapy. - 2014. - No59. – P. 11-12.

13. Karaulov A.V. Use of azoximer bromide for treatment of children’s inflammatory infections of respiratory system: a meta-analysis of controlled clinical studies/ A.V. Karaulov, A.V. Gorelov// Infectology magazine.- 2019. – V4, No11. – P. 31-41. DOI: 10.22625/2072-6732-2019-11-4-31-41

14. Karaulov A.V. Immunomodulating therapy and respiratory viral infections: an immunologist’s point of view / A.V. Karaulov //Pulmonology, - 2015. – V25, No1. – P. 106- 111. DOI: 10.18093/0869-0189-2015-25-1-106-111

15. KolbinA. Use of immunostimulatory drags in therapy of Children Respiratory Infections. An Evidence-Based Medicine Perspective/ A. Kolbin, A. Kharchev //Pediatric Pharmacology. - 2007. – V4, No3. – P.26-34.

16. Result improving in Therapy of Respiratory Infections / A.I. Martynov, A.G. Malyavin, M.V. Juravlevа [et al.] //Preventive medicine - 2019. - V22, No4. – P. 144-151. DOI 10.17116/profmed201922041144

17. Krivapalov A.A. The role of modern immunomodulators in treatment and prevention of upper respiratory tract and diseases / A.A. Krivapalov, K.Ju. Sherban //Medical advice. - 2017. - No16. - P. 68-72. DOI: 10.21518/2079-701X-2017-16-68-72

18. Krjuchkova T.A. Groprinosin for modern possibilities of clinical use in the therapy and prevention of acute respiratory diseases in a group of often and long-term ill children/ T.A. Krjuchkova // Scientific Bulletin of Belgorod State University. Series: Medicine. Pharmacy. – 2014. - V24, No195. – P. 27-29

19. Clinical efficacy of the immunomodulatory agent cycloferon (tablets) in viral respiratory infections: Results of a systematic review and meta-analysis / N.K.Mazina, I.V. Sheshunov, P.V. Mazin[et al.] //Therapeutic archive.– 2017. - No11. – P. 84-92. DOI: 10.17116/terarkh2017891184-92

20. Marushko J.V. The use of the drug Derinat in a complex of therapeutic and prophylactic measures in frequently ill children with allergic pathology/ J.V. Marushko, O.S. Movchan, N.G. Bychkova //Modern Pediatrics. – 2012. – V.1, No41. – P. 28-32.

21. Moerchuk V.I. Meta-analysis of the effectiveness of the use of the domestic immunomodulatory drug Derinat in the complex therapy of acute respiratory viral infection in children/ V.I. Moerchuk, V.S. Bortnickiy, A.A. Genkel //Actual aspects of import substitution of foreign drugs by domestic ones from the standpoint of evidence-based medicine. – 2016. - P. 59-66

22. Mustafaev D.M. Immunomodulatory therapy in ENT practice/ D.M. Mustafaev, V.I.Egorov // Medical advice. - 2016. - No18. – P. 94-100. DOI: 10.21518/2079-701X-2016-18-94-100

23. ENT: nationalguideline/ PalchunV.T.- GEOTAR-Media, 2020. – 1024p.

24. Approaches to the treatment of acute respiratory infections and influenza with a seasonal increase/ Nisevich L.L., Volkov K.S., Alekseeva A.A. [et al.] //VSP – 2015. - No1. DOI: 10.21518/2079-701X-2016-18-94-100

25. Expert council resolution Actualization of clinical guidelines for acute rhinosinusitis and their adaptation for EPOS 2020.

26. Savenkova M.S. Clinical experience in the treatment of respiratory diseases with Groprinosin (inosinpranobex) in pediatric practice/ M.S. Savenkova, A.A. Afanasyeva, G.M. Balakireva // Pediatrics. ConsiliumMedicum, - 2018. - No4.– P. 32-36. DOI: 10.26442/24138460.2018.4.180112

27. Immunomodular therapy o fARVI and Fluby the Derinatdrug/ Filatov O.J., Kashaeva O.V., Gordeeva M.A. [et al.] // Archive of Internal Medicine. – 2012. - V2, No4. – P. 30-34.

28. Uchaikin V.F. On the issue of Expanding the indications of the use of an immunomodulating Drug in the Treatment and Prevention of influenza and acute respiratory infections in Young Children / V.F.Uchaikin //Children’s infections. – 2017. - V3, No16. – P. 54-58. DOI: 10.22627/2072-8107-2017-16-3-54-58

29. Kharif S.M. Azoximer bromide is a safe and effective preparation for the treatment of acute respiratory infections of the upper respiratory tract in children: an overview of the results of double-blind, placebo-controlled, randomized clinical trials of Phase II and III /S.M. Kharif, A.N. Galustyan //ConsiliumMedicum. Pediatrics – 2017. - No2:- P. 55-61.

30. European Position Paper on Rhinosinusitis and Nasal Polyps 2020 (EPOS 2020) DOI: 10.4193/rhin19.080

31. Family Medicine Residency/ Fashner J., Ericson K., Werner S. [et al.] //Mishawaka, Indiana// Am Fam Physician. – 2012. - V86. – No2. – P.153-159

32. Kenealy T. Antibiotics for the common cold and acute purulent rhinitis / Kenealy T., Arroll B. // Cochrane Database Syst Rev. - 2013

33. Pruzinec P.The safety profile of Polyoxidonium in daily practice: results from postauthorization safety study in Slovakia / Pruzinec P., Chirun N., Sveikata A. – 2018.

34. URL: https://www.rlsnet.ru/tn_index_id_6942.htm

35. URL: https://www.rospotrebnadzor.ru


Review

For citations:


Lebedeva N.A., Tomin D.S., Vinokurov M.M., Terekhina K.G. Immunomodulators in the treatment of acute respiratory viral infections. Yakut Medical Journal. 2021;(2):27-30. https://doi.org/10.25789/YMJ.2021.74.07

Views: 4


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1813-1905 (Print)
ISSN 2312-1017 (Online)